US2017087090A1PendingUtilityA1

Portable powder delivery system and method

Assignee: SYNERGY CHC CORPPriority: Apr 20, 2009Filed: Dec 14, 2016Published: Mar 30, 2017
Est. expiryApr 20, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61K 31/616A61K 33/10A61K 31/167A61K 31/451A61M 2202/064A61K 31/135A61K 31/522A61K 9/14A61M 5/31A61K 9/145A61K 31/60A61J 1/03A61K 31/29A61K 31/138A61K 31/7016A61K 45/06
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A vehicle to carry a powered medication that addresses the limitations of the prior art. It includes a system and method. A powder delivery system includes a first panel and a second panel coupled together around a periphery of the panels to form a sealed void therebetween, each the panel having a width and length about equal to a standard credit card width and length, respectively; and a powder, disposed in the void, having a quantity at least about equal to an active dose of the powder, wherein a thickness of the panels with the powder disposed therebetween is not greater than about 0.1 inches and more preferably not greater than about 0.03 inches.

Claims

exact text as granted — not AI-modified
1 .- 14 . (canceled) 
     
     
         15 . A powder medicine delivery system, comprising:
 a first panel and a second panel coupled together around a periphery of said panels to form a sealed void therebetween; and   a powder medicine, disposed in said void, having a quantity at least about equal to an active dose of said powder medicine;   at least one additive disposed in said void with said powder medicine;   wherein said panels are flexible and a thickness of said panels with said powder medicine disposed therebetween is not greater than about 0.1 inches, and wherein the panels with said powder medicine disposed therebetween have a length not greater than about 3⅜ inches and a width not greater than about 2⅛ inches.   
     
     
         16 . The powder delivery system of  claim 15  wherein said panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof. 
     
     
         17 . The powder delivery system of  claim 15  further comprising at least two tear-initiation notches for facilitating opening said sealed void to access said powder medicine disposed therein. 
     
     
         18 . The powder delivery system of  claim 17  wherein said panels are generally waterproof. 
     
     
         19 . The powder delivery system of  claim 15  wherein said dose is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof. 
     
     
         20 . The powder delivery system of  claim 15  further comprising a detachable hangtag coupled to said coupled panels. 
     
     
         21 . The powder delivery system of  claim 15  wherein a construction of said panels with said powder medicine disposed therebetween retains a flat profile that further resists premature access to said sealed void and exposure of said powder medicine responsive to compressive forces applied to said panels. 
     
     
         22 . A medicine powder delivery method, comprising:
 (a) providing a sealed void by sealing edges of two powder contamination-resistant panels together, said panels having a length not greater than about 3⅜ inches and a width not greater than about 2⅛ inches;   (b) providing a medicine powder within the sealed void; and   (c) providing at least one additive in said void with said medicine powder, said panels with said medicine powder and said at least one additive disposed within said sealed void having a thickness not greater than about 0.1 inches, wherein said panels are resistant to tearing, puncturing, and moisture while being flexible and pliable and wherein a construction of said panels with said powder disposed therebetween retains a flat profile that further resists premature access to said sealed void and exposure of said medicine powder responsive to compressive forces applied to said panels.   
     
     
         23 . The method of  claim 22  wherein said medicine powder is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof. 
     
     
         24 . A medication package, comprising:
 a first flexible panel and a second flexible panel coupled together around a periphery of said flexible panels to form a sealed void therebetween;   a powder medication disposed in said void, having a quantity at least about equal to an active dose of said powder medication; and   at least one additive disposed in said void with said powder medication;   wherein a thickness of the medication package with said powder medication and said at least one additive disposed therein is not greater than about 0.1 inches.   
     
     
         25 . The medication package of  claim 24  wherein said first and second panels are resistant to tearing, puncturing, and moisture. 
     
     
         26 . The medication package of  claim 24  wherein said first and second panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof. 
     
     
         27 . The medication package  claim 24  wherein said dose is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof. 
     
     
         28 . The method of  claim 22  further comprising providing a detachable hangtag coupled to said coupled panels. 
     
     
         29 . The medication package of  claim 24  wherein the panels have a width not greater than about 2⅛ inches and a length not greater than about 3⅜ inches. 
     
     
         30 . The medication package of  claim 24  further comprising a detachable hangtag coupled to said coupled panels. 
     
     
         31 . The method of  claim 22  wherein a quantity of said medicine powder is at least about equal to an active dose of said powder medicine. 
     
     
         32 . The method of  claim 22  wherein said panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof.

Join the waitlist — get patent alerts

Track US2017087090A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.